(NASDAQ:EDIT), In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates supports EDIT-401's potential as a best-in-class, one-time therapy Company on track to submit IND/CTA for EDIT-401 by mid-2026 and achieve initial human proof-of-concept data by year-end 2026 Extended cash runway into the third quarter of 2027, enabling […]

Perma-Fix Reports Financial Results and Provides Business Update for the Third Quarter of 2025 GlobeNewswire November 10, 2025 ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Mark Duff, President and Chief

(TSX-V:ELBM),(NASDAQ:ELBM), TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company“), a leader in advancing North America's critical minerals processing, announces the issuance of a major mechanical, piping, electrical and instrumentation (“SMPEI”) tender package as part of its refinery construction works in Temiskaming Shores, Ontario. The

Zacatecas Silver Secures Community Access Agreement at Panuco and Signs Drill Contract with Major Drilling GlobeNewswire November 10, 2025 VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC; OTC: ZCTSF; FSE: 7TV) is pleased to announce that it has entered into a new community access agreement with the Ejido Panuco

(NasdaqGM:RYTM), – Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic obesity on concomitant treatment with GLP-1 therapy – – Analysis of data from Phase 3 TRANSCEND trial show clinically meaningful changes in cardiometabolic parameters in patients with acquired hypothalamic obesity treated with setmelanotide for 52 weeks –

Atana Unveils Organizational Insights to Close Learning Gaps and Reduce Risk Through Strategic Intelligence Signature Training and Analytics Approach Turns Workplace Training into Actionable Outcomes GlobeNewswire November 10, 2025 BELLEVUE, Wash., Nov. 10, 2025 (GLOBE NEWSWIRE) — Atana, the leading behavior-based learning and development solutions provider, today announced the general availability of Atana Organizational Insights.

(Other OTC:OTCM),(OTC US:OTCM),(Other OTC:OGOFF),(TSX-V:OGO),(Boerse Frankfurt – Freiverkehr:OGF0.F), NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Organto Foods Inc. (TSX-V: OGO; FSE: OGF0; OTCQX: OGOFF), an integrated provider of organic and specialty produce, has qualified to trade

Electra Moves Cobalt Refinery Build Forward with Major Construction Tender GlobeNewswire November 10, 2025 TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company“), a leader in advancing North America's critical minerals processing, announces the issuance of a major mechanical, piping, electrical and instrumentation (“SMPEI”) tender

(NASDAQ:LOT), NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the third quarter 2025 on November 24, 2025, before market opening in the United States. The Company's management

Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek(R) 2025 GlobeNewswire November 10, 2025 – Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic obesity on concomitant treatment with GLP-1 therapy – – Analysis of data from Phase 3 TRANSCEND trial show clinically meaningful changes in cardiometabolic parameters